Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07017790
Amino Acid PET to Assess the Efficacy of IDH Inhibitor Treatments for IDH Mutated Gliomas
Sponsor: Central Hospital, Nancy, France
View on ClinicalTrials.gov
Summary
Amino acid PET imaging could represent a biomarker for the evaluation of IDH inhibitor treatments for patients with refractory IDH-mutated gliomas
Official title: Amino Acid PET Imaging to Assess the Efficacy of IDH Inhibitor Treatments for Patients With Refractory IDH Mutated Gliomas
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
OBSERVATIONAL
Enrollment
22
Start Date
2025-06-30
Completion Date
2025-08-30
Last Updated
2025-06-12
Healthy Volunteers
No
Conditions
Interventions
OTHER
Amino-acid PET
Patients received 18-fluoroDopa then a PET exam
Locations (1)
CHRU of NANCY
Vandœuvre-lès-Nancy, France